Location of Repository

Pharmacotherapy in Endocrinology: Diabetes, Obesity, and Hyper¬lipidemia- Review Article

By Mania RADFAR and Mohammad ABDOLLAHI

Abstract

<p>The field of endocrine pharmacology is very wide but most of studies in the recent years from the world and Iran have focused on diabetes, osteoporosis, and lipid disorders. In the present review, we tried to evaluate the improvements and publications in that field briefly. Interestingly, many of studies have focused on agents that have traditional and natural origin. Although few basic studies have gone on the direct line to complete preclinical and some clinical trial studies, there are many non-clinical studies that have proved efficacy of many compounds in endocrine diseases but these studies were not continued at clinical stages to reach a drug. However, it is appreciable that, some researchers have given novel ideas that deserve investment by grant bodies to reach out valuable works. We believe that science of endocrine pharmacology is still young and more quality studies are still needed to introduce effective medications for diseases like diabetes and osteoporosis or even obesity and lipid disorders.</p><p><strong> </strong></p><p><strong>Keywords: </strong>Pharmacotherapy,<strong> </strong>Diabetes, Osteoporosis, Lipid disorders, Emerging therapies</p

Topics: Public aspects of medicine, RA1-1270, Medicine, R
Publisher: Tehran University of Medical Sciences
Year: 2015
OAI identifier: oai:doaj.org/article:e4960771ddde437a9c8f8aed59d54673
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2251-6093 (external link)
  • https://doaj.org/toc/2251-6085 (external link)
  • http://ijph.tums.ac.ir/index.p... (external link)
  • https://doaj.org/article/e4960... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.